EdoxabanBleeding: 14 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1805卷 / 1期

关键词：

D O I：

10.1007/s40278-020-78828-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：118 / 118

相关论文

共 50 条

[31] PembrolizumabVarious toxicities: 14 case reports
Reactions Weekly, 2021, 1867 (1) : 345 - 345
[32] Bevacizumab/triamcinoloneEndophthalmitis: 14 case reports
Reactions Weekly, 2023, 1960 (1) : 105 - 105
[33] ImmunosuppressantsVarious toxicities: 14 case reports
Reactions Weekly, 2017, 1649 (1) : 141 - 141
[34] BrolucizumabIntraocular inflammation: 14 case reports
Reactions Weekly, 2022, 1891 (1) : 77 - 77
[35] AntineoplasticsVarious toxicities: 14 case reports
Reactions Weekly, 2023, 1977 (1) : 39 - 40
[36] InfliximabVarious toxicities: 14 case reports
Reactions Weekly, 2020, 1805 (1) : 168 - 168
[37] AnamorelinVarious toxicities: 14 case reports
Reactions Weekly, 2025, 2042 (1) : 40 - 40
[38] CarbamazepineDRESS syndrome: 14 case reports
Reactions Weekly, 2017, 1682 (1) : 85 - 85
[39] CaffeineVarious toxicities: 14 case reports
Reactions Weekly, 2022, 1916 (1) : 120 - 120
[40] PrednisoneBreakthrough candidaemia: 14 case reports
Reactions Weekly, 2017, 1654 (1) : 289 - 289

← 1 2 3 4 5 →